bacterial sinusitis

bacterial sinusitis (bak·tēˑ·rē·l sīˈ·n·sīˑ·tis),

n an inflammation of the sinus cavities, open air passageways within the human body, caused by bacteria such as streptococci, staphylococci, pneumococci, or
Haemophilus influenzae. Prevalent symptoms include congestion in the nasal passages and pain, tenderness, and swelling in the approximate area of the affected cavity. Headaches, chills, and fever may also occur. In some cases, it may develop immediately after a viral infection in the upper respiratory tract.
References in periodicals archive ?
Acute Bacterial Sinusitis Clinical Trials Review - http://www.
Neoplasia is an uncommon cause of sinusitis, and in this case, the macaw's initial presentation and blood test, cytologic, and imaging results did not show evidence of neoplasia; moreover, the initial presentation and findings were characteristic of a bacterial sinusitis.
The American Academy of Pediatrics (AAP) defines acute bacterial sinusitis as infection lasting less than 30 days.
The patient was initially diagnosed with acute bacterial sinusitis and discharged on oral clindamycin.
We also have two short articles on the management of acute bacterial sinusitis and chronic suppurative otitis media.
Acute bacterial sinusitis may be considered when symptoms persist for longer than 10 days.
In many people allergic sinusitis occurs before the bacterial sinusitis, so allergic sinusitis should be treated to avoid the opportunistic bacterial growth.
However, any cold that appears to last for longer than that may be a secondary bacterial sinusitis infection and antibiotics may be needed.
Draft guidance documents have been issued for acute bacterial otitis media, acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis, community-acquired bacterial pneumonia, noninferiority clinical trial design, and acute bacterial skin and skin structure infections.
Acute bacterial sinusitis in children can be complicated by orbital or periorbital cellulitis, and epidural, subdural, or brain abscesses.
introduction in 1996, LEVAQUIN has gained widespread use in the treatment of adults for a variety of bacterial infections caused by specific pathogens, including: acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, nosocomial pneumonia, community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections (mild to moderate), chronic bacterial prostatitis, complicated and uncomplicated urinary tract infections (mild to moderate) and acute pyelonephritis (mild to moderate).
The FDA said the changes include the removal of two of the three previously approved indications - acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis - from the drug's label.